BACITRACIN: A NEW ANTIBIOTIC PRODUCED BY A MEMBER OF THE B. SUBTILIS GROUP
- PMID: 17770204
- DOI: 10.1126/science.102.2650.376
BACITRACIN: A NEW ANTIBIOTIC PRODUCED BY A MEMBER OF THE B. SUBTILIS GROUP
Abstract
A new antibiotic "bacitracin" has been recovered from a strain of the B. subtilis group of organisms. It is neutral, water-soluble, non-toxic and relatively heat stable. In vitro it is active chiefly against Grampositive organisms, but the gonococcus and meningococcus are susceptible to its action. It is also active in vivo against experimentally produced hemolytic streptococcal infections in mice and gas gangrene infections in guinea pigs. Clinical use in hemolytic streptococcal and staphylococcal infections in man have given encouraging results.
Similar articles
-
Polypeptide antibiotic 26a from Bacillus subtilis. IV. Evaluation of biological in vivo activity.Acta Microbiol Pol. 1978;27(4):375-81. Acta Microbiol Pol. 1978. PMID: 86285
-
[Comparison of latex agglutination and bacitracin-SXT methods used for the identification of 142 beta-hemolytic streptococci].Mikrobiyol Bul. 1991 Oct;25(4):326-9. Mikrobiyol Bul. 1991. PMID: 1795656 Turkish.
-
[Frequency and in vitro antibiotic sensitivity of bacitracin-resistant beta-hemolytic streptococci from throat swab specimens].Mikrobiyol Bul. 1989 Oct;23(4):312-7. Mikrobiyol Bul. 1989. PMID: 2488937 Turkish.
-
[Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].Rev Esp Quimioter. 2007 Sep;20(3):261-76. Rev Esp Quimioter. 2007. PMID: 18080024 Review. Spanish.
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
Cited by
-
The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.Antimicrob Agents Chemother. 2016 Aug 22;60(9):5427-36. doi: 10.1128/AAC.02965-15. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27381394 Free PMC article.
-
The treatment of pyogenic skin infections with bacitracin ointment.Can Med Assoc J. 1951 May;64(5):395-7. Can Med Assoc J. 1951. PMID: 14831040 Free PMC article. No abstract available.
-
The Results of the Systemic Administration of the Antibiotic, Bacitracin, in Surgical Infections: A Preliminary Report.Ann Surg. 1948 Oct;128(4):714-29. Ann Surg. 1948. PMID: 17859227 Free PMC article. No abstract available.
-
Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.Pharmaceutics. 2023 Jul 5;15(7):1893. doi: 10.3390/pharmaceutics15071893. Pharmaceutics. 2023. PMID: 37514078 Free PMC article. Review.
-
Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes Bacteria.J Bacteriol. 2011 Aug;193(15):3851-62. doi: 10.1128/JB.05175-11. Epub 2011 Jun 10. J Bacteriol. 2011. PMID: 21665979 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources